跳到正文
研踪PaperTrail

论文库

检索计算机领域论文,按研究方向、作者或关键词筛选。

部分采集异常
正在读取账号与研究记录…

全站更新概况

+0新增论文
+0其中 AI 相关
+2已有论文修订
+100新增 AI 导读

arXiv 最近完成扫描:2026-11-15 03:37 · 全站最近入库:2026-11-14 15:09各信源进度 →

统计口径与数据新鲜度

统计 2026-11-14 04:10 — 2026-11-15 04:10(北京时间) · 点击数字查看对应简报;AI 相关包含在新增论文内。

最近完成检查:2026-11-15 03:37最近发现新增版本:2026-11-14 15:09库内论文最新更新时间:2026-11-13 02:59

每分钟刷新已保存的数据。空检查不代表采集异常;新收录可能包含历史论文。AI 导读按新增版本计数。

23,348 已收录论文19,580 AI 相关6,729 有修订112 HF 社区发现

浏览论文库

时间范围跟随排序:版本更新、本站收录或首次发表。最新收录可能包含历史论文。部分信源异常,查看状态 →

找到 2 篇论文 · 按版本更新时间排序上轮扫描起点 2026-11-15 03:36(北京时间)
版本更新 · v4arXiv:2602.12162

Amortized Molecular Optimization via Group Relative Policy Optimization

Muhammad bin Javaid, Hasham Hussain, Ashima Khanna-Reiter, Berke Kişin, Jonathan Pirnay, Alexander Mitsos, Dominik G. Grimm, Martin Grohe

原文摘要

In structurally constrained molecular optimization, state-of-the-art methods treat every new input structure as a separate instance, restarting an expensive oracle-driven search from scratch and scaling poorly to settings with many starting structures or expensive oracles. While amortized approaches that learn a transferable policy could in principle remove this bottleneck, existing methods struggle to generalize to diverse structural constraints at inference time. We present AMORTIX, a Graph Transformer model that natively supports such constraints, optimizing molecular structures in a single rollout with zero inference-time oracle calls. A central challenge for amortized training in this domain is that optimization difficulty varies drastically across starting structures. We address this by centering rewards within groups of completions that share the same starting structure. We evaluate on goal-directed scaffold decoration, including single- and multi-target kinase inhibitor design, and on a few-shot prodrug case study. AMORTIX outperforms both amortized baselines and search-based instance optimizers on kinase scaffold decoration, and ablations across 23 objectives show that group-relative centering improves over REINFORCE and PPO and is substantially more consistent across scaffold splits. The prodrug case study further demonstrates transfer of learned modification rules to unseen drug structures.

cs.LG

版本更新 · v2arXiv:2602.10984

Sample Efficient Generative Molecular Optimization with Joint Self-Improvement

Serra Korkmaz, Adam Izdebski, Jonathan Pirnay, Rasmus Møller-Larsen, Michal Kmicikiewicz, Pankhil Gawade, Maksim Pavlov, Dominik G. Grimm 等 9 位作者

原文摘要

Generative molecular optimization aims to design molecules with properties surpassing those of existing compounds. However, evaluating candidate molecules is expensive, so sample efficiency, i.e., generating optimized molecules within a fixed evaluation budget, is essential. Moreover, in the offline setting, where a surrogate model approximates candidate evaluation, sample inefficiency compounds with surrogate error, further limiting performance. To address these challenges, we introduce Joint Self-Improvement (JSI), a framework for sample-efficient online and offline molecular optimization. JSI combines (i) a joint generative-predictive model trained via a joint likelihood-based loss, which aligns molecule generation and surrogate modeling, and (ii) inference-time self-improvement, which iteratively biases the generative component of the joint model toward higher-scoring molecules, using direct objective function evaluations in the online setting and the predictive component in the offline setting. Experiments across docking score optimization in both online and offline settings, as well as antimicrobial peptide optimization, demonstrate that JSI outperforms state-of-the-art methods under limited evaluation budgets. Code is available at https://github.com/szczurek-lab/jsi.

cs.LG